Minovia Therapeutics Reports in Science Translational Medicine on First Clinical Data Demonstrating Disease-Modifying Efficacy and Safety of Mitochondrial Augmentation Therapy in Pediatric Patients with Primary Mitochondrial Diseases

December 21, 2022

Skip to content